In-Vitro Inflammatory Bowel Disease (IBD) Diagnostic Industry - Regional Synopsis
Regionally, the in-vitro inflammatory bowel disease (IBD) diagnostic market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America industry is estimated to account for largest revenue share of 44% by 2037, backed by the increasing prevalence of IBD amongst the individuals in the region, followed by the presence of a strong healthcare network in countries such as the United States, as well as for the rising healthcare expenditure in the countries in the region. The market in the region garnered a revenue of USD 723.24 Million in the year 2019, and it is further expected to reach USD 1067.01 Million by the end of 2028. The in-vitro inflammatory bowel disease (IBD) diagnostic market in the region is also anticipated to grow with the highest CAGR of 5.7% during the forecast period.
On the other hand, the market in Europe is expected to hold the second-leading market share and attain a revenue of USD 915.66 Million by the end of 2028. Amongst the countries in the region, the in-vitro inflammatory bowel disease (IBD) diagnostic market in Germany is anticipated to garner the second-largest revenue of USD 165.08 Million by the end of 2028, up from a revenue of USD 110.09 Million in 2019.
